A facile synthesis and neuroprotective role of novel quinoxaline-2,3-bis hydrazones in ethidium bromide-induced demyelinated rats
暂无分享,去创建一个
[1] Nicole Fruehauf,et al. Theory And Practice Of Histotechnology , 2016 .
[2] J. Banerjee,et al. Quinoxaline as a potent heterocyclic moiety , 2014 .
[3] V. Saini,et al. Therapeutic Potential of Hydrazones as Anti-Inflammatory Agents , 2014, International journal of medicinal chemistry.
[4] D. Magnuson,et al. Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord , 2013, Experimental Neurology.
[5] K. Padmini,et al. A Review on Biological Importance of Hydrazones , 2013 .
[6] R. Fernández,et al. Design and synthesis of new bis-hydrazones and pyridine bis-hydrazones: application in the asymmetric Diels-Alder reaction , 2013 .
[7] M. Thakur,et al. Synthesis and spectral characterisation of hydrazone based 14-membered octaaza macrocyclic Ni ( II ) complexes , 2012 .
[8] W. Dehaen,et al. Synthesis and properties of hydrazones bearing amide, thioamide and amidine functions , 2010 .
[9] E. Bondan,et al. Ethidium bromide-induced demyelination in the sciatic nerve of diabetic rats. , 2009, Arquivos de neuro-psiquiatria.
[10] G. Chejfec. Robbins Pathologic Basis of Disease , 2009 .
[11] Moses Rodriguez. Advances in multiple Sclerosis and Experimental Demyelinating Diseases , 2008 .
[12] M. Deshmukh,et al. Synthesis of Some 4‐Substituted Hydrazinotetrazolo[1,5‐a]quinoxalines , 2007 .
[13] G. Olayiwola,et al. Synthesis and neuropharmacological activity of some quinoxalinone derivatives , 2007 .
[14] E. Bondan,et al. Delayed Schwann cell and oligodendrocyte remyelination after ethidium bromide injection in the brainstem of Wistar rats submitted to streptozotocin diabetogenic treatment. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[15] Kazunori Fukuchi,et al. Design and synthesis of novel 7-heterocycle-6-trifluoromethyl-3-oxoquinoxaline-2-carboxylic acids bearing a substituted phenyl group as superior AMPA receptor antagonists with good physicochemical properties. , 2006, Bioorganic & medicinal chemistry.
[16] Anna M Wu,et al. Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.
[17] E. Russo,et al. AMPA receptor antagonists as potential anticonvulsant drugs. , 2005, Current topics in medicinal chemistry.
[18] C. Fernandes,et al. Ethidium bromide-induced demyelination of the sciatic nerve of adult Wistar rats. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[19] J. Li. Synthesis of Novel 3-Substituted Pyrrolo[2,3-b]quinoxalines via an Intramolecular Heck Reaction on an Aminoquinoxaline Scaffold. , 1999, The Journal of organic chemistry.
[20] D. Lodge,et al. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model , 1992, Brain Research.
[21] P. Anthony. Robbins' Pathologic Basis of Disease , 1990 .